Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 177 - 184 of 12107 results
Trump Signs Most-Favored-Nation Executive Order - Potential Impact on Drug Supply Chain
May 14, 2025| Blog| Viewpoint
Twenty States Sue the Trump Administration for HHS Program Eliminations and Staff Layoffs
May 14, 2025| Blog| Viewpoint
Former US Attorney for Maryland Joins Am Law 100 Firm
May 13, 2025| News
Technical CCPA Violations Result in $345,178 Fine from California Privacy Protection Agency
May 12, 2025| Blog| Viewpoint
Appeals Court Rejects AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program
May 12, 2025| Blog| Viewpoint
Ex-Maryland US Atty Joins Mintz as Crisis Management Head
May 12, 2025| News
Erek Barron, Former US Attorney for Maryland, Joins DC Law Firm
May 12, 2025| News
Erek Barron Joins New Law Firm After Tenure as US Attorney for MD
May 12, 2025| News
News & Press Releases
Mintz Honored with NLADA Beacon of Justice Award
August 21, 2025
Mintz will receive a 2025 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) for efforts to sustain equal justice for families and communities. This is the sixth consecutive year that Mintz has won this award.
SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals
August 19, 2025
Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.
Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree
August 19, 2025
Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
Events
Podcasts
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|